Phase I Dose Escalation Study of Pirarubicin in Combination with Cyclophosphamide in Breast Cancer

被引：0
|
作者：
Sakata, M. [1 ]
Jinno, H. [1 ]
Hayashida, T. [1 ]
Takahashi, M. [1 ]
Sato, T. [1 ]
Seki, H. [1 ]
Shimada, K. [1 ]
Nishiya, S. [1 ]
Kitagawa, Y. [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo, Tokyo, Japan
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P5-10-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-10-13
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer
    Infante, Jeffrey R.
    Jones, Suzanne F.
    Bendell, Johanna C.
    Spigel, David R.
    Yardley, Denise A.
    Weekes, Colin D.
    Messersmith, Wells A.
    Hainsworth, John D.
    Burris, Howard A., III
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (02) : 199 - 205
  • [42] Phase I Dose-escalation Study of (SBRT) for Localizes Prostate Cancer
    Ghaly, M.
    Marrero, M.
    Vijeh, L.
    Montchal, E.
    Lee, L.
    Potters, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S391 - S391
  • [43] Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer
    R D Kim
    S R Alberts
    C Peña
    I Genvresse
    A Ajavon-Hartmann
    C Xia
    A Kelly
    J E Grilley-Olson
    British Journal of Cancer, 2018, 118 : 462 - 470
  • [44] Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer
    Kim, R. D.
    Alberts, S. R.
    Pena, C.
    Genvresse, I.
    Ajavon-Hartmann, A.
    Xia, C.
    Kelly, A.
    Grilley-Olson, J. E.
    BRITISH JOURNAL OF CANCER, 2018, 118 (04) : 462 - 470
  • [45] Dose-escalation models for combination phase I trials in oncology
    Hamberg, Paul
    Ratain, Mark J.
    Lesaffre, Emmanuel
    Verweij, Jaap
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2870 - 2878
  • [46] PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED BREAST-CANCER
    LEVI, JA
    BEITH, JM
    SNYDER, RD
    TATTERSALL, MH
    BELL, D
    WHEELER, H
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (05): : 474 - 478
  • [47] Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
    Khawaja, Muhammad R.
    Nick, Alpa M.
    Madhusudanannair, Vinu
    Fu, Siqing
    Hong, David
    McQuinn, Lacey M.
    Ng, Chaan S.
    Piha-Paul, Sarina A.
    Janku, Filip
    Subbiah, Vivek
    Tsimberidou, Apostolia
    Karp, Daniel
    Meric-Bernstam, Funda
    Lu, Karen H.
    Naing, Aung
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (05) : 973 - 977
  • [48] Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
    Muhammad R. Khawaja
    Alpa M. Nick
    Vinu Madhusudanannair
    Siqing Fu
    David Hong
    Lacey M. McQuinn
    Chaan S. Ng
    Sarina A. Piha-Paul
    Filip Janku
    Vivek Subbiah
    Apostolia Tsimberidou
    Daniel Karp
    Funda Meric-Bernstam
    Karen H. Lu
    Aung Naing
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 973 - 977
  • [49] A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML
    Welch, John S.
    Niu, Haixia
    Uy, Geoffrey L.
    Westervelt, Peter
    Abboud, Camille N.
    Vij, Ravi
    Stockerl-Goldstein, Keith E.
    Jacoby, Meagan
    Pusic, Iskra
    Schroeder, Mark A.
    Dipersio, John F.
    Cashen, Amanda F.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (08) : E103 - E108
  • [50] A phase I dose-escalation study of ABT-888 (veliparib) in combination with carboplatin in HER2-negative metastatic breast cancer (MBC).
    Viswanathan, S.
    Wesolowski, R.
    Layman, R. M.
    Alejandra, G.
    Miller, B.
    Chalmers, J. J.
    Bejastani, S.
    Zhao, W.
    Pierluigu, G.
    Cotrill, J.
    Phelps, M. A.
    Schaaf, L. J.
    Geyer, S. M.
    Hall, N.
    Knopp, M. V.
    Shapiro, C. L.
    Villalona-Calero, M. A.
    Chen, A.
    Grever, M. R.
    Ramaswamy, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345